We served as healthcare regulatory counsel to Oak HC/FT, a venture capital firm investing in early to growth stage tech-enabled companies, in its $75 million Series C investment in Truepill. Truepill currently owns and operates six pharmacies across the U.S. The funds will be used to launch an at-home lab testing network – a new service that will further expand Truepill’s ecosystem of direct-to-patient capabilities, which includes Truepill Health telehealth network, pharmacy fulfillment, a custom-built EMR, and more.
Oak HC/FT Invests in Truepill
You Also May Be Interested In:
Successful Defense of National Home Healthcare Provider in Appealing $18 Million Extrapolated Overpayment Resulting from UPIC Audit
We successfully defended a national home healthcare provider in appealing an $18 million extrapolated overpayment resulting from a UPIC audit.
Advise a public university system on compliance with the rules associated with grants and contracts from NIH, NSF, and the Department of Defense